Loading...
BioStem Technologies, Inc.
BSEM•PNK
Healthcare
Biotechnology
$11.64
$-0.22(-1.82%)
BioStem Technologies, Inc. (BSEM) Financial Performance & Income Statement Overview
Review BioStem Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1708.93%
↑ 1708.93%
Operating Income Growth
501.09%
↑ 501.09%
Net Income Growth
475.86%
↑ 475.86%
Operating Cash Flow Growth
799.54%
↑ 799.54%
Operating Margin
10.34%
↑ 10.34%
Gross Margin
95.39%
↑ 95.39%
Net Profit Margin
10.98%
↑ 10.98%
ROE
149.88%
↑ 149.88%
ROIC
75.40%
↑ 75.40%
BioStem Technologies, Inc. (BSEM) Income Statement & Financial Overview
Review BioStem Technologies, Inc.'s (BSEM) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $102.87M | $82.56M | $74.49M | $41.90M |
| Cost of Revenue | $3.59M | $4.24M | $3.80M | $2.28M |
| Gross Profit | $99.28M | $78.32M | $70.69M | $39.63M |
| Gross Profit Ratio | $0.97 | $0.95 | $0.95 | $0.95 |
| R&D Expenses | $1.27M | $482495.00 | $85154.00 | $70748.00 |
| SG&A Expenses | $89.53M | $68.49M | $61.79M | $34.95M |
| Operating Expenses | $90.80M | $69.03M | $61.87M | $35.02M |
| Total Costs & Expenses | -$94.39M | $73.26M | $65.67M | $37.30M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $65751.00 | $138478.00 | $142722.00 | $163942.00 |
| Depreciation & Amortization | $77847.00 | $54038.00 | $87623.00 | $53665.00 |
| EBITDA | $8.56M | $9.35M | $8.91M | $4.66M |
| EBITDA Ratio | $0.08 | $0.11 | $0.12 | $0.11 |
| Operating Income | $8.48M | $9.29M | $8.82M | $4.61M |
| Operating Income Ratio | $0.08 | $0.11 | $0.12 | $0.11 |
| Other Income/Expenses (Net) | -$63254.00 | -$139289.00 | -$142837.00 | -$165509.00 |
| Income Before Tax | $8.42M | $9.15M | $8.68M | $4.44M |
| Income Before Tax Ratio | $0.08 | $0.11 | $0.12 | $0.11 |
| Income Tax Expense | -$7.10M | $2.33M | $2.31M | $521.00 |
| Net Income | $15.52M | $6.82M | $6.36M | $4.44M |
| Net Income Ratio | $0.15 | $0.08 | $0.09 | $0.11 |
| EPS | $0.94 | $0.42 | $0.39 | $0.27 |
| Diluted EPS | $0.68 | $0.32 | $0.30 | $0.20 |
| Weighted Avg Shares Outstanding | $16.43M | $16.32M | $16.30M | $16.32M |
| Weighted Avg Shares Outstanding (Diluted) | $22.77M | $21.13M | $20.92M | $22.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan